Stringent Validation and Quality Control Ensure Confidence in Antibodies and Results
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today released the first set in a new product line of PrecisonAb™ Antibodies, rigorously validated for use in western blotting. These antibodies offer superior sensitivity, specificity, and reliability. They also come with the industry’s most complete validation data so researchers can accurately assess the antibodies’ performance before buying, and a positive control lysate so researchers can optimize the antibodies in their own labs. These are the first of thousands of PrecisionsAb Antibodies Bio-Rad plans to release in order to help researchers improve their western blotting results.
Scientists have struggled with antibody unreliability for decades because manufacturing standards and quality control vary widely among vendors, targets, and even among antibody lots.
“There’s a huge discrepancy between the claims of antibody performance from vendors and what scientists encounter when the actual product arrives,” said ...
